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Abstract
Introduction: We report the case of a patient with orbital malignant lymphoma that was not
detected by imaging studies when she presented with impaired vision, which lead to her eventual
loss of sight.
Case presentation: A 71-year-old Japanese woman complained of deteriorating vision in her left
eye. On examination, papilledema was detected, but magnetic resonance imaging only showed
slight thickening and enhancement of the left optic nerve. A diagnosis of idiopathic optic neuritis
was made and corticosteroid pulse therapy was administered. During the next four months, the
patient received a total of four courses of corticosteroid pulse therapy, but she still suffered from
bilateral loss of vision. A second magnetic resonance imaging procedure revealed tumors in both
orbits and a biopsy showed diffuse large B-cell malignant lymphoma.
Conclusion:  The possibility of malignant lymphoma should be considered in patients with
recurrent optic neuropathy despite administration of corticosteroid pulse therapy, even when
there are no abnormalities on cerebrospinal fluid examination or magnetic resonance imaging.
Introduction
Primary malignant lymphoma is relatively frequent
among orbital tumors [1] and is usually not difficult to
detect because it forms a mass lesion that causes changes
such as proptosis [2]. Primary malignant lymphoma of
the orbit can present with palpebral swelling, proptosis,
tumor formation, diplopia, blepharoptosis, and ocular
displacement [1], but few authors have reported orbital
lymphoma presenting with optic neuropathy [2]. In
patients with visual disorders, imaging generally reveals
compression of the optic nerve by the tumor.
Here we report the case of a patient with orbital lym-
phoma that was not detected by imaging studies at the
time when she developed the initial symptom of visual
impairment, and which eventually lead to loss of sight. It
is very rare for imaging studies to only show optic nerve
swelling despite marked bilateral loss of vision, as
occurred in this case.
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Case presentation
On the 2nd February 2005, a previously healthy 71-year-
old Japanese woman consulted our hospital due to
reduced vision in the left eye. A full ophthalmological
examination revealed that her visual acuity was 20/20 in
the right eye and 20/60 in the left eye. There was no rela-
tive afferent pupil defect (RAPD). On funduscopy, the left
eye showed papilledema. Goldmann perimetry of the left
eye showed mild central depression, enlargement of Mar-
iotte's blind spot, and paracentral scotoma. Fluorescein
angiography showed early hyperfluorescence of the disc.
The results of hematology tests, renal and liver function
tests, urine analysis, chest radiography, and computed
tomography were all within normal limits. Magnetic reso-
nance imaging (MRI) of the head and orbits showed that
the left optic nerve was slightly thicker than the right optic
nerve (Figure 1a, b).
A diagnosis of idiopathic optic neuritis was made and cor-
ticosteroid pulse therapy was started on February 3rd.
After four days, her visual acuity was 20/20 oculus sinister
(OS) and the swelling of the left optic disk had already
resolved. The patient's response to corticosteroid therapy
and her age suggested a diagnosis of autoimmune optic
neuritis. On March 14th and April 12th, visual acuity was
reduced to 20/200 OS. There was neither RAPD nor any
abnormal ocular findings. Corticosteroid pulse therapy
was started again because her vision had deteriorated after
reduction of the steroid dose. However, visual acuity on
the left side declined to no light perception by May 10th.
On May 20th, the right eye showed a decrease of acuity to
20/600 despite the absence of abnormal ocular findings.
On May 24th, the patient was again started on corticoster-
oid pulse therapy. An MRI of the head and orbits revealed
swelling of the left optic nerve (Figure 1c, d). Cerebrospi-
nal fluid (CSF) examination did not show any increase in
cell count, abnormal cells or any other findings. On June
3rd, hemorrhage was detected around the left optic disk.
On June 10th, slight papilledema was observed on the
patient's right eye. Visual acuity declined to no light per-
ception on the right side by June 21st. On July 4th, she
complained of left eye pain, and proptosis and subcutane-
ous hemorrhage were noted around the eyes which sug-
gested thrombosis of tumor pressure.
On July 5th, an MRI revealed mass lesions in the patient's
left and right orbits. Three days later, an orbital tumor
biopsy was performed at the Department of Neurosurgery
(Figure 1e, f). Pathological examination gave a diagnosis
of diffuse large B-cell lymphoma (Figure 2). Imaging stud-
ies showed intraparenchymal optic nerve disease, thus
suggesting the possibility of breakout into the surround-
ing orbital soft tissue because tumor cells were found in
the soft tissue and fibroadipose tissue through orbital
tumor biopsy.
Immunohistochemical studies showed that the tumor
cells were negative for expression of T cell markers (CD3
and CD56) and for Ki-1 (CD30), which is a marker of
Hodgkin's and Reed-Sternberg cells. The cells were also
negative for cell marker p53 and Epstein-Barr virus-
Magnetic resonance images of the head and orbits Figure 1
Magnetic resonance images of the head and orbits. (a) 
Initial coronal image (unenhanced T2-weighted) showing the 
left optic nerve to be thicker and more enhanced than the 
right optic nerve. (b) Transverse (enhanced T1-weighted) 
coronal image showing the left optic nerve to be thicker and 
more enhanced than the right optic nerve. (c) Coronal 
(enhanced T2-weighted) image obtained after loss of vision in 
both eyes, which shows that the right optic nerve has high 
signal intensity while the left optic nerve is swollen. (d) 
Transverse (enhanced T1-weighted) coronal image obtained 
after loss of vision in both eyes, which shows that the right 
optic nerve has high signal intensity while the left optic nerve 
is swollen. (e) Coronal (enhanced T1-weighted) image 
obtained six months after presentation displays bilateral 
orbital tumors. (f) Transverse (enhanced T1-weighted) coro-
nal image obtained six months after presentation displays 
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encoded small RNA. Instead, the atypical lymphocytes
expressed the B cell markers CD20 and CD79a (data not
shown).
On July 28th, the patient was referred to another hospital
for chemotherapy and radiotherapy. The succeeding 42
months showed no evidence of local recurrence or sys-
temic metastasis of the lymphoma.
Discussion
The tumor found in our patient may have developed
around her optic nerves and caused compression until the
second course of corticosteroid pulse therapy was admin-
istered. Although visual acuity recovered during corticos-
teroid pulse therapy, it deteriorated again after the dose
was decreased. These dose-dependent changes of the vis-
ual symptoms suggest that circulatory impairment related
to the perivascular infiltration of tumor cells led to rapid
loss of vision during the period before the tumor could be
detected by MRI.
Almost all orbital lymphomas can be diagnosed from
swelling of the optic nerve on imaging studies and from
abnormal findings upon examination of the CSF [3-5].
However, there was no optic nerve swelling in our patient
until after the third course of corticosteroid pulse therapy
was administered. Therefore, orbital lymphoma can
sometimes cause loss of sight without being detected by
imaging.
Conclusion
The possibility of orbital lymphoma should be considered
in patients with an early recurrence of optic neuropathy
after corticosteroid pulse therapy, even when there are no
abnormal findings on CSF examination or MRI.
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The resected orbital tumor shows infiltration of the extraoc- ular muscles Figure 2
The resected orbital tumor shows infiltration of the 
extraocular muscles. Tumor biopsy was carried out six 
months after presentation. The tumor cells are large, polygo-
nal, or round and the nuclei are folded, cleaved, or kidney-
shaped. Mitoses and prominent nuclear abnormalities can be 
seen. The pathological diagnosis was diffuse large B cell lym-
phoma (hematoxylin-eosin, × 50).